Dr. Donald Johann, Associate Professor of Biomedical Informatics and Internal Medicine, is among the national leaders to coauthor a second important paper published recently in the high-impact journal Genome Biology. The paper concerns the establishment of new actionable guidelines for cancer gene panel-based Next Generation Sequencing (NGS) and will help to better facilitate the rapid implementation, validation and quality control of oncopanel testing in clinical use. UAMS is involved in national efforts to bring more advanced NGS assays to the clinic for our patients.